| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $653K | — | -36.3% |
| Cost of Revenue | $708K | — | +7.9% |
| Gross Profit | -$55K | — | -114.9% |
| R&D Expense | $468K | — | -11.7% |
| SG&A Expense | $2.4M | — | +80.0% |
| Operating Income | -$3.7M | — | -100.4% |
| Pre-tax Income | -$3.8M | — | -52.8% |
| Income Tax | $33K | — | +120.0% |
| Net Income | -$3.8M | — | -53.2% |
| EPS (Basic) | -$6.88 | — | +77.0% |
| EPS (Diluted) | -$6.88 | — | -272.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.2M | -47.1% | +291.4% |
| Accounts Receivable | $332K | +14.9% | -7.3% |
| Inventory | $2.3M | -3.0% | +12.2% |
| Current Assets | $6.2M | -14.8% | +60.6% |
| Total Assets | $39.9M | -3.0% | -9.6% |
| Current Liabilities | $6.9M | +3.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | -221.1% |
| Capital Expenditures | $17K | — | +240.0% |
| Investing Cash Flow | -$17K | — | -111.9% |
| Financing Cash Flow | $2.3M | — | +122.9% |
| Free Cash Flow | -$4.3M | — | -221.1% |
| -16.3% |
| Total Liabilities | $7.9M | +3.0% | -6.8% |
| Stockholders' Equity | $32.0M | -4.4% | -10.3% |